PT UBC Medical Indonesia Tbk (IDX:LABS)

Market Cap	572.75B +27.2%
Revenue (ttm)	205.85B +35.1%
Net Income	12.07B +211.6%
EPS	3.06 +211.6%
Shares Out	3.95B
PE Ratio	47.46
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	5,232,900
Open	152.00
Previous Close	151.00
Day's Range	142.00 - 152.00
52-Week Range	120.00 - 260.00
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Jul 29, 2026

About IDX:LABS

PT UBC Medical Indonesia Tbk distributes medical devices in Indonesia. The company operates in two segments, Medical Disposables and Consumables, and Diagnostics and Equipment. It offers next generation molecular, retina AI, infectious disease, HPV DNA test, real time PCR, TB management, and newborn screening products. The company was founded in 2014 and is based in Jakarta Timur, Jakarta. PT UBC Medical Indonesia Tbk operates as a subsidiary of PT Optel Investama Mulia.

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 2014
• Employees: 54
• Stock Exchange: Indonesia Stock Exchange
• Ticker Symbol: LABS

Financial Performance

In 2025, IDX:LABS's revenue was 199.30 billion, an increase of 34.99% compared to the previous year's 147.64 billion. Earnings were 13.51 billion, an increase of 357.50%.